Ibrutinib as a single agent and in combination with dexamethasone showed anti-tumour activity in multiple myeloma

Hope for avoiding chemo in patients with Hodgkins lymphoma

Combination therapy for high-risk MDS? Not quite yet

Should young adults with acute lymphocytic leukaemia receive paediatric treatment protocols?

Results of HD2000 trial comparing combination therapies in advanced-stage Hodgkin's lymphoma

Characterising the findings of the peripheral T-cell lymphoma registry

ASH 2014: Highlights in mantle cell lymphoma

ASH 2014: Highlights in multiple myeloma

Tyrosine kinase inhibitor in combination with chemo shows benefit in acute myeloid leukaemia

New cytarabine combinations could overcome toxicities in AML treatment

Paediatric leukaemia treatment regimens lead to improved outcomes in adolescents and young adults

Targeted therapy effective in elderly patients with Philadelphia-positive acute lymphocytic leukaemia